Torphasol 10 mg/ml Solution for Injection for Horses

None.

Special precautions for safe use in the target species:
Safety and efficacy of butorphanol in foals have not been established. In foals, use
the veterinary medicinal product only according to the benefit/risk assessment by the
responsible veterinarian.
Due to its antitussive properties, butorphanol may lead to an accumulation of mucous
in the respiratory tract. Therefore, in animals with respiratory diseases associated
with increased mucous production or in animals that are being treated with
expectorants, butorphanol should only be used on the basis of a risk-benefit analysis
by the responsible veterinarian.
The use of the veterinary medicinal product at the recommended dose may lead to
transient ataxia and/or excitement. Therefore, to prevent injuries in patient and
people, the location for the treatment should be chosen carefully.
Butorphanol / detomidine hydrochloride combination:
Routine cardiac auscultation should be performed prior to use in combination with
detomidine.
AN: 03314/2024 & 03318/2024
Special precautions to be taken by the person administering the veterinary medicinal
product to animals:
Direct contact with skin or eye of the user should be avoided since the veterinary
medicinal product might induce irritation and sensitization. Accidental spillage on the
skin should be washed immediately with soap and water. When the veterinary
medicinal product comes into contact with the eyes, rinse immediately with plenty of
water.
Care should be taken when handling the veterinary medicinal product to avoid self-
injection. In case of accidental self-injection, seek medical advice immediately and
show the package leaflet or the label to the physician, and DO NOT DRIVE, since
drowsiness, nausea and dizziness may occur. Effects can be reversed by the
administration of an opioid antagonist.
Special precautions for the protection of the environment:
Not applicable.